500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
Posted on: Thursday, 28 May 2009, 12:32 CDT
Alejandra had been diagnosed a few weeks after birth with left
ventricular non compaction and dilative cardiomyopathy, a disease that causes
the heart muscle to enlarge and weaken. From six months of age, she received
medications for her heart disease, but as she progressively worsened, she had
to be placed on the waiting list for a donor heart. She presented to Dr.
Alejandra was placed on ECMO, a modified version of a heart-lung machine,
on
By the time she received the Berlin Heart EXCOR Pediatric VAD, she had spent 38 days on mechanical ventilation and three days on ECMO. Alejandra's mother recalls, "We were devastated and very anxious. We had to hope for a miracle to help Alejandra."
Full story under: http://www.berlinheart.com/500th_EXCOR_Pediatric_Patient_full_story.pdfPictures available.
About EXCOR(R) Pediatric
The EXCOR Pediatric Ventricular Assist Device is a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure. EXCOR Pediatric has been used in more than 500 pediatric patients worldwide ranging from newborns with 2.2 kg body weight to teenagers. EXCOR is currently under clinical investigation for pediatric patients in USA.
About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces,
and distributes implantable and external ventricular assist devices (also
called mechanical heart support systems) for patients of every age and body
size. The company is market leader in
The company also manufactures the implantable left ventricular assist
device INCOR(R), which has been designed for long-term application in adult
patients. The longest the device has supported a patient so far is more than
five and a half years and ongoing. INCOR is not FDA approved, but widely used
in
SOURCE Berlin Heart GmbH
Source: PR Newswire
Related Articles
- Project Lifesaver International Receives Federal Assistance for the Missing Alzheimer's Patient Assistance Program
- Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
- NPSF Issues New Universal Patient Compact During Patient Safety Awareness Week
- Heart Disease and Lung Cancer Won't Wait, But Patients May Have to Wait for Life-Saving Care
- Journal of Cardiovascular Electrophysiology Publishes Study on Time-Saving Approach to Optimizing Timing for Heart Failure and ICD Devices
- Study Analyzes Pharmaceutical Patient Education and Patient Advocacy
- ADDING MULTIMEDIA Abiomed Receives FDA Approval of The AbioCor(R), the World's First Completely Self-Contained, Implantable Artificial Heart; AbioCor Granted Humanitarian Device Exemption
- Aspirin Unsurpassed in Prevention of Heart Attack and Stroke in Wide Range of Patients
- Review Article Indicated That Optimal Device Choice for Pediatric Asthma Drug Delivery Is the One Patients Prefer
- Abbott Receives U.S. Approval for New Device Designed to Treat Patients at Risk of Stroke
User Comments (0)

RSS Feeds